Patient-derived organoids recapitulate glioma-intrinsic immune program and progenitor populations of glioblastoma
PNAS Nexus · 01.02.2024 · 3 (2)
DOI: 10.1093/pnasnexus/pgae051 ↗Kurz gefasst
Fachartikel in der Zeitschrift PNAS Nexus, online erschienen am 02.02.2024. Verfasst von Fumihiro Watanabe und 9 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Neural Stem Cells and Functional Neurogenetics, Department of Neurology, UConn Health Brain and Spine Institute, 5 Munson Road, Farming…. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, NINDS NIH HHS, NCI.
Abstract (Originalsprache)
Glioblastoma multiforme (GBM) is a highly lethal human cancer thought to originate from a self-renewing and therapeutically-resistant population of glioblastoma stem cells (GSCs). The intrinsic mechanisms enacted by GSCs during 3D tumor formation, however, remain unclear, especially in the stages prior to angiogenic/immunological infiltration. In this study, we performed a deep characterization of the genetic, immune, and metabolic profiles of GBM organoids from several patient-derived GSCs (GBMO). Despite being devoid of immune cells, transcriptomic analysis across GBMO revealed a surprising immune-like molecular program, enriched in cytokine, antigen presentation and processing, T-cell receptor inhibitors, and interferon genes. We find two important cell populations thought to drive GBM progression, Special AT-rich sequence-binding protein 2 (SATB2+) and homeodomain-only protein homeobox (HOPX+) progenitors, contribute to this immune landscape in GBMO and GBM in vivo. These progenitors, but not other cell types in GBMO, are resistant to conventional GBM therapies, temozolomide and irradiation. Our work defines a novel intrinsic immune-like landscape in GBMO driven, in part, by SATB2+ and HOPX+ progenitors and deepens our understanding of the intrinsic mechanisms utilized by GSCs in early GBM formation.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Laboratory of Neural Stem Cells and Functional Neurogenetics, Department of Neurology, UConn Health Brain and Spine Institute, 5 Munson Road, Farmington, CT 06030, USA.
- Departments of Neuroscience, Neurology, Genetics and Genome Sciences, UConn Health, Farmington, CT 06030, USA.
- Center on Aging UConn Health, Farmington, CT 06030, USA.
- The Steve and Cindy Rasmussen Institute for Genomic Medicine, Nationwide Children's Hospital, Columbus, OH 43215, USA.
- Department of Pediatrics, The Ohio State University College of Medicine, Columbus, OH 43210, USA.
- Department of Neuroscience, The Ohio State University Wexner Medical Center, Columbus, OH 43210, USA.
ORCID-Profile: Fumihiro Watanabe, Jenna M Bartley, Mark E Hester, Paula Schiapparelli, Alfredo Quiñones-Hinojosa, Jaime Imitola
Förderung
- NCI NIH HHS
- NINDS NIH HHS
- NCI
- NIH
- Mayo Clinic
- NRI
- Biogen-UConn Collaboration
Zitieren
APA
Watanabe, F., Hollingsworth, E. W., Bartley, J. M., Wisehart, L., Desai, R., Hartlaub, A. M., Hester, M. E., Schiapparelli, P., Quiñones-Hinojosa, A., & Imitola, J. (2024). Patient-derived organoids recapitulate glioma-intrinsic immune program and progenitor populations of glioblastoma. PNAS Nexus, 3(2). https://doi.org/10.1093/pnasnexus/pgae051
Vancouver
Watanabe F, Hollingsworth EW, Bartley JM, Wisehart L, Desai R, Hartlaub AM, et al. Patient-derived organoids recapitulate glioma-intrinsic immune program and progenitor populations of glioblastoma. PNAS Nexus. 2024;3(2). doi:10.1093/pnasnexus/pgae051
BibTeX
@article{Watanabe2024,
author = {Watanabe, Fumihiro and Hollingsworth, Ethan W and Bartley, Jenna M and Wisehart, Lauren and Desai, Rahil and Hartlaub, Annalisa M and Hester, Mark E and Schiapparelli, Paula and Quiñones-Hinojosa, Alfredo and Imitola, Jaime},
title = {Patient-derived organoids recapitulate glioma-intrinsic immune program and progenitor populations of glioblastoma},
journal = {PNAS Nexus},
year = {2024},
volume = {3},
number = {2},
doi = {10.1093/pnasnexus/pgae051}
}
EUVIMED